SCHEMBL5100970

SCHEMBL5100970

ClC=CC#Cc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.50
GRM5 P41594 3/20 0.41
MAPT P10636 3/20 0.39
CYP3A4 P08684 3/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
THPO P40225 1/20 0.38
BLM P54132 1/20 0.37
PMP22 Q01453 1/20 0.37
HCAR2 Q8TDS4 1/20 0.36
NPC1 O15118 2/20 0.35
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
HPGD P15428 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MTOR P42345 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5100967 1.00 APP (0.50) APPGRM5MAPTCYP3A4CYP1A2
SCHEMBL5507858 0.85 APP (0.61) APPGRM5MAPTCYP3A4CYP1A2
SCHEMBL5507856 0.85 APP (0.61) APPGRM5MAPTCYP3A4CYP1A2
SCHEMBL9146168 0.85 APP (0.61) APPGRM5MAPTCYP3A4CYP1A2
SCHEMBL6244468 0.80 APP (0.55) APPGRM5MAPTCYP3A4CYP1A2
SCHEMBL18712243 0.77 GRM5 (0.45) GRM5MAPTNPC1ALDH1A1MEN1
SCHEMBL9434307 0.76 APP (0.50) APPGRM5MAPTCYP3A4CYP1A2
SCHEMBL5487421 0.76 APP (0.44) APPGRM5MAPTCYP3A4CYP1A2
SCHEMBL5487427 0.76 APP (0.44) APPGRM5MAPTCYP3A4CYP1A2
SCHEMBL3888887 0.74 APP (0.48) APPGRM5MAPTCYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7332623-B2 Aryl-substituted acyclic enediyne compounds KAOHSIUNG MEDICAL UNIVERSITY (TW) 2008-02-19 US disclosed
US-20050004212-A1 Aryl-substituted acyclic enediyne compounds KAOHSIUNG MEDICAL UNIVERSITY 2005-01-06 US disclosed
US-20050004211-A1 Pharmaceutical compositions comprising aryl-substituted acyclic enediyne compounds KAOHSIUNG MEDICAL UNIVERSITY 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004211-A1 Pharmaceutical compositions comprising aryl-substituted acyclic enediyne compounds CCNI, TOP1, TOP2B APP 2731/4885GRM5 2746/4885MAPT 3753/4885
US-20050004212-A1 Aryl-substituted acyclic enediyne compounds CCNI, TOP2B, TOP2A APP 3886/4885GRM5 4209/4885MAPT 3887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.